Sofie Hædersdal

@HenrikMaagensen, winner of the EASD Early Career Academy Best abstract prize elegantly guides us through HNF1A-MODY (MODY3) and the use of SGLT2-inhibitors with similar glucose excretion compared with type 2 diabetes @Stenodiabetes #EASD2024 #CardioMetabolicPrevention

Excellent presentations by @Hagelqvist72567 and @KaisarMaytham that created a lot of attention at the big stage in Madrid Hall #EASD2024 @Stenodiabetes #CardioMetabolicPrevention @TinaVilsb @Christi04644231

@DanielJDrucker @Filip_Knop Full text link available rdcu.be/c7SzL

A huge thanks to @DanielJDrucker and @Filip_Knop for sharing 🙏